IMMUNOGENICITY AND SAFETY OF AN ADJUVANTED INACTIVATED SUBUNIT INFLUENZA VACCINE TO THOSE OF A NON-ADJUVANTED INACTIVATED SUBUNIT INFLUENZA VACCINE, WHEN ADMINISTERED TO ADULTS AFFECTED BY CHRONIC DISEASES: